Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Abortion, Induced | 29 | 2023 | 82 | 11.000 |
Why?
|
Contraception | 18 | 2023 | 57 | 7.920 |
Why?
|
Pregnancy | 66 | 2023 | 1503 | 5.050 |
Why?
|
Intrauterine Devices | 9 | 2022 | 18 | 4.170 |
Why?
|
Contraceptive Agents, Female | 11 | 2022 | 23 | 3.800 |
Why?
|
Uterine Hemorrhage | 7 | 2020 | 14 | 3.700 |
Why?
|
Blood Loss, Surgical | 5 | 2018 | 13 | 2.870 |
Why?
|
Contraception Behavior | 9 | 2020 | 31 | 2.860 |
Why?
|
Female | 97 | 2023 | 19873 | 2.760 |
Why?
|
Levonorgestrel | 9 | 2022 | 16 | 2.670 |
Why?
|
Misoprostol | 10 | 2023 | 26 | 2.520 |
Why?
|
Humans | 104 | 2024 | 34853 | 2.220 |
Why?
|
Oxytocin | 3 | 2022 | 24 | 2.150 |
Why?
|
Hawaii | 34 | 2024 | 1878 | 2.140 |
Why?
|
Family Planning Services | 7 | 2022 | 29 | 2.120 |
Why?
|
Adult | 57 | 2023 | 11034 | 2.110 |
Why?
|
Students, Medical | 3 | 2024 | 121 | 1.960 |
Why?
|
Pregnancy in Adolescence | 4 | 2016 | 33 | 1.930 |
Why?
|
Intrauterine Devices, Medicated | 4 | 2020 | 11 | 1.930 |
Why?
|
Intrauterine Devices, Copper | 4 | 2022 | 4 | 1.880 |
Why?
|
Young Adult | 37 | 2023 | 4012 | 1.850 |
Why?
|
Pregnancy, Unplanned | 8 | 2021 | 28 | 1.740 |
Why?
|
Gestational Age | 10 | 2020 | 190 | 1.710 |
Why?
|
Sexually Transmitted Diseases | 4 | 2019 | 165 | 1.670 |
Why?
|
Obesity | 7 | 2017 | 965 | 1.600 |
Why?
|
Contraceptives, Oral, Combined | 6 | 2020 | 12 | 1.590 |
Why?
|
Anticoagulants | 3 | 2017 | 97 | 1.510 |
Why?
|
Cesarean Section | 9 | 2022 | 53 | 1.480 |
Why?
|
Oxytocics | 3 | 2019 | 8 | 1.480 |
Why?
|
Abortifacient Agents | 4 | 2022 | 12 | 1.480 |
Why?
|
Adolescent | 30 | 2023 | 5035 | 1.470 |
Why?
|
Analgesics | 2 | 2022 | 56 | 1.470 |
Why?
|
Doxycycline | 4 | 2015 | 30 | 1.470 |
Why?
|
Delivery, Obstetric | 4 | 2017 | 38 | 1.460 |
Why?
|
Health Knowledge, Attitudes, Practice | 8 | 2017 | 790 | 1.410 |
Why?
|
Metrorrhagia | 5 | 2020 | 7 | 1.410 |
Why?
|
Postoperative Complications | 3 | 2019 | 206 | 1.340 |
Why?
|
Retrospective Studies | 22 | 2022 | 1961 | 1.320 |
Why?
|
Attitude of Health Personnel | 4 | 2018 | 186 | 1.300 |
Why?
|
Mifepristone | 10 | 2023 | 33 | 1.260 |
Why?
|
Pain | 2 | 2022 | 249 | 1.230 |
Why?
|
Pregnancy Outcome | 4 | 2018 | 90 | 1.190 |
Why?
|
Heparin, Low-Molecular-Weight | 3 | 2017 | 7 | 1.180 |
Why?
|
Data Collection | 3 | 2019 | 188 | 1.160 |
Why?
|
Body Mass Index | 5 | 2017 | 775 | 1.140 |
Why?
|
Labor, Induced | 2 | 2016 | 4 | 1.130 |
Why?
|
Pregnancy, Ectopic | 2 | 2022 | 14 | 1.130 |
Why?
|
Obstetrics | 6 | 2020 | 38 | 1.100 |
Why?
|
Dilatation and Curettage | 2 | 2018 | 4 | 1.060 |
Why?
|
Abortion, Spontaneous | 4 | 2022 | 25 | 1.020 |
Why?
|
Overweight | 4 | 2017 | 233 | 0.990 |
Why?
|
Patient Satisfaction | 4 | 2019 | 141 | 0.990 |
Why?
|
Pharmacy | 2 | 2022 | 26 | 0.980 |
Why?
|
Health Services Accessibility | 6 | 2022 | 531 | 0.940 |
Why?
|
Perineum | 2 | 2014 | 10 | 0.930 |
Why?
|
United States | 18 | 2023 | 3894 | 0.920 |
Why?
|
Contraceptives, Oral, Hormonal | 2 | 2015 | 13 | 0.910 |
Why?
|
Weight Gain | 2 | 2015 | 128 | 0.880 |
Why?
|
Gynecology | 5 | 2018 | 31 | 0.880 |
Why?
|
Contraception, Postcoital | 2 | 2013 | 9 | 0.850 |
Why?
|
Pregnancy, Unwanted | 2 | 2021 | 10 | 0.850 |
Why?
|
Intraoperative Complications | 2 | 2019 | 18 | 0.850 |
Why?
|
Pharmacists | 1 | 2022 | 53 | 0.840 |
Why?
|
Double-Blind Method | 8 | 2022 | 269 | 0.830 |
Why?
|
Postpartum Period | 3 | 2018 | 59 | 0.790 |
Why?
|
Gonorrhea | 1 | 2021 | 31 | 0.780 |
Why?
|
Internship and Residency | 3 | 2013 | 121 | 0.780 |
Why?
|
Contraceptive Agents | 4 | 2022 | 13 | 0.760 |
Why?
|
Anti-Bacterial Agents | 2 | 2015 | 355 | 0.760 |
Why?
|
Health Personnel | 2 | 2020 | 200 | 0.750 |
Why?
|
Premature Birth | 1 | 2021 | 71 | 0.750 |
Why?
|
Urinary Incontinence | 3 | 2014 | 15 | 0.730 |
Why?
|
Needle-Exchange Programs | 1 | 2019 | 7 | 0.720 |
Why?
|
Abortifacient Agents, Nonsteroidal | 3 | 2018 | 9 | 0.720 |
Why?
|
Age Factors | 3 | 2018 | 1007 | 0.720 |
Why?
|
Social Values | 2 | 2016 | 30 | 0.720 |
Why?
|
Physicians | 2 | 2020 | 148 | 0.700 |
Why?
|
Communication | 2 | 2017 | 170 | 0.690 |
Why?
|
Sexual Behavior | 4 | 2016 | 587 | 0.690 |
Why?
|
Preconception Care | 1 | 2018 | 6 | 0.690 |
Why?
|
Chlamydia Infections | 1 | 2021 | 196 | 0.680 |
Why?
|
Social Control, Formal | 1 | 2018 | 9 | 0.680 |
Why?
|
Pregnancy Trimester, Second | 3 | 2017 | 16 | 0.670 |
Why?
|
Anesthesia, Obstetrical | 2 | 2017 | 6 | 0.660 |
Why?
|
Hemostatics | 1 | 2018 | 8 | 0.650 |
Why?
|
Needs Assessment | 1 | 2019 | 159 | 0.650 |
Why?
|
Women's Health | 2 | 2015 | 135 | 0.650 |
Why?
|
Directive Counseling | 1 | 2017 | 13 | 0.630 |
Why?
|
Laminaria | 1 | 2017 | 3 | 0.630 |
Why?
|
Dilatation | 1 | 2017 | 3 | 0.620 |
Why?
|
Pelvic Organ Prolapse | 2 | 2014 | 5 | 0.610 |
Why?
|
Obstetric Surgical Procedures | 1 | 2017 | 1 | 0.610 |
Why?
|
Self-Examination | 1 | 2017 | 8 | 0.610 |
Why?
|
Telemedicine | 4 | 2021 | 163 | 0.610 |
Why?
|
Intention | 1 | 2017 | 84 | 0.600 |
Why?
|
Obstetric Labor Complications | 2 | 2014 | 8 | 0.590 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 40 | 0.580 |
Why?
|
Trust | 1 | 2017 | 119 | 0.570 |
Why?
|
Reproductive Health Services | 1 | 2015 | 9 | 0.560 |
Why?
|
Adolescent Health Services | 1 | 2015 | 27 | 0.550 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2015 | 47 | 0.540 |
Why?
|
Venous Thromboembolism | 1 | 2015 | 14 | 0.540 |
Why?
|
Pregnancy Complications | 4 | 2015 | 132 | 0.540 |
Why?
|
Patient Care Planning | 2 | 2017 | 14 | 0.530 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2015 | 88 | 0.520 |
Why?
|
Curriculum | 3 | 2014 | 237 | 0.520 |
Why?
|
Endometrium | 1 | 2015 | 57 | 0.510 |
Why?
|
Tocolysis | 1 | 2014 | 2 | 0.510 |
Why?
|
Tocolytic Agents | 1 | 2014 | 3 | 0.510 |
Why?
|
Nifedipine | 1 | 2014 | 12 | 0.510 |
Why?
|
Tachycardia | 1 | 2014 | 11 | 0.510 |
Why?
|
Warfarin | 2 | 2017 | 59 | 0.510 |
Why?
|
Internet | 2 | 2013 | 204 | 0.510 |
Why?
|
Hypotension | 1 | 2014 | 21 | 0.510 |
Why?
|
Abdomen | 1 | 2014 | 12 | 0.510 |
Why?
|
Pressure | 1 | 2014 | 36 | 0.500 |
Why?
|
Sterilization, Tubal | 2 | 2020 | 3 | 0.490 |
Why?
|
Lacerations | 1 | 2014 | 6 | 0.490 |
Why?
|
Cross-Sectional Studies | 9 | 2019 | 2561 | 0.490 |
Why?
|
Ultrasonography, Prenatal | 3 | 2021 | 33 | 0.480 |
Why?
|
Health Policy | 1 | 2015 | 149 | 0.480 |
Why?
|
Ambulatory Care Facilities | 2 | 2011 | 61 | 0.480 |
Why?
|
Information Services | 1 | 2013 | 14 | 0.470 |
Why?
|
Inservice Training | 1 | 2013 | 30 | 0.470 |
Why?
|
Hysteroscopy | 1 | 2012 | 1 | 0.450 |
Why?
|
Treatment Outcome | 6 | 2020 | 1349 | 0.440 |
Why?
|
Labor Stage, First | 1 | 2012 | 2 | 0.440 |
Why?
|
Prospective Studies | 5 | 2015 | 1353 | 0.440 |
Why?
|
Self Efficacy | 1 | 2013 | 173 | 0.440 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2012 | 7 | 0.430 |
Why?
|
Prenatal Diagnosis | 1 | 2012 | 10 | 0.430 |
Why?
|
Amniotic Fluid | 1 | 2012 | 15 | 0.430 |
Why?
|
Pain Measurement | 4 | 2022 | 161 | 0.430 |
Why?
|
Progestins | 1 | 2011 | 14 | 0.420 |
Why?
|
Ethinyl Estradiol | 1 | 2011 | 9 | 0.420 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2011 | 11 | 0.420 |
Why?
|
Contraceptives, Postcoital | 3 | 2017 | 7 | 0.420 |
Why?
|
Micronesia | 4 | 2018 | 87 | 0.410 |
Why?
|
Balloon Occlusion | 1 | 2011 | 3 | 0.410 |
Why?
|
Surgical Wound Dehiscence | 1 | 2011 | 7 | 0.410 |
Why?
|
Middle Aged | 12 | 2021 | 9642 | 0.410 |
Why?
|
Postnatal Care | 1 | 2011 | 12 | 0.400 |
Why?
|
Abortifacient Agents, Steroidal | 1 | 2010 | 3 | 0.390 |
Why?
|
Pregnancy Trimester, First | 4 | 2022 | 24 | 0.390 |
Why?
|
Pilot Projects | 3 | 2019 | 628 | 0.380 |
Why?
|
Ambulatory Care | 1 | 2011 | 76 | 0.380 |
Why?
|
Medical Staff, Hospital | 1 | 2010 | 13 | 0.370 |
Why?
|
Counseling | 2 | 2023 | 105 | 0.370 |
Why?
|
Domestic Violence | 1 | 2009 | 24 | 0.360 |
Why?
|
Diabetes, Gestational | 1 | 2010 | 46 | 0.360 |
Why?
|
Pharmacies | 2 | 2023 | 19 | 0.360 |
Why?
|
Problem-Based Learning | 1 | 2009 | 32 | 0.360 |
Why?
|
Headache | 1 | 2009 | 18 | 0.360 |
Why?
|
Pregnant Women | 1 | 2010 | 48 | 0.350 |
Why?
|
Male | 11 | 2023 | 18870 | 0.350 |
Why?
|
Educational Measurement | 1 | 2009 | 80 | 0.350 |
Why?
|
Logistic Models | 5 | 2020 | 894 | 0.340 |
Why?
|
Education, Medical, Undergraduate | 1 | 2009 | 75 | 0.340 |
Why?
|
Uterine Perforation | 1 | 2008 | 1 | 0.330 |
Why?
|
Health Status | 1 | 2011 | 356 | 0.330 |
Why?
|
Condoms | 2 | 2019 | 132 | 0.310 |
Why?
|
Time Factors | 3 | 2019 | 1681 | 0.300 |
Why?
|
Cervix Uteri | 2 | 2018 | 43 | 0.290 |
Why?
|
Health Surveys | 3 | 2017 | 358 | 0.280 |
Why?
|
Mass Screening | 1 | 2009 | 427 | 0.280 |
Why?
|
Education, Medical, Graduate | 2 | 2017 | 53 | 0.270 |
Why?
|
Lidocaine | 2 | 2017 | 15 | 0.270 |
Why?
|
Ibuprofen | 2 | 2022 | 33 | 0.270 |
Why?
|
Prevalence | 3 | 2024 | 1425 | 0.260 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2005 | 38 | 0.260 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 187 | 0.250 |
Why?
|
Perception | 2 | 2019 | 183 | 0.240 |
Why?
|
Infant, Newborn | 2 | 2021 | 871 | 0.240 |
Why?
|
Attitude to Health | 2 | 2021 | 311 | 0.240 |
Why?
|
Sex Education | 2 | 2016 | 29 | 0.240 |
Why?
|
Analgesics, Opioid | 2 | 2022 | 176 | 0.240 |
Why?
|
Adolescent Behavior | 2 | 2016 | 243 | 0.230 |
Why?
|
Forecasting | 1 | 2024 | 124 | 0.230 |
Why?
|
Insurance, Health | 1 | 2023 | 120 | 0.230 |
Why?
|
Pharmaceutical Services | 1 | 2023 | 22 | 0.220 |
Why?
|
Insurance Coverage | 2 | 2020 | 99 | 0.220 |
Why?
|
Labor Pain | 1 | 2022 | 2 | 0.220 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2022 | 5 | 0.220 |
Why?
|
Birth Weight | 2 | 2015 | 93 | 0.220 |
Why?
|
Fetal Research | 1 | 2022 | 4 | 0.220 |
Why?
|
Fentanyl | 1 | 2022 | 7 | 0.220 |
Why?
|
Oxycodone | 1 | 2022 | 4 | 0.220 |
Why?
|
Religion | 1 | 2023 | 77 | 0.220 |
Why?
|
Linear Models | 1 | 2023 | 253 | 0.210 |
Why?
|
Acetaminophen | 1 | 2022 | 24 | 0.210 |
Why?
|
Follow-Up Studies | 2 | 2018 | 964 | 0.210 |
Why?
|
Odds Ratio | 2 | 2017 | 517 | 0.210 |
Why?
|
Qualitative Research | 5 | 2023 | 393 | 0.210 |
Why?
|
Drug Implants | 2 | 2020 | 19 | 0.210 |
Why?
|
Confidentiality | 2 | 2021 | 26 | 0.210 |
Why?
|
Postal Service | 1 | 2021 | 7 | 0.200 |
Why?
|
Pregnancy Tests | 1 | 2021 | 1 | 0.200 |
Why?
|
Focus Groups | 2 | 2019 | 307 | 0.200 |
Why?
|
Patient Education as Topic | 2 | 2013 | 207 | 0.200 |
Why?
|
Chlamydia trachomatis | 1 | 2021 | 66 | 0.200 |
Why?
|
Desogestrel | 1 | 2020 | 4 | 0.190 |
Why?
|
Labor, Obstetric | 1 | 2020 | 15 | 0.190 |
Why?
|
Tamoxifen | 1 | 2020 | 61 | 0.190 |
Why?
|
Norpregnadienes | 2 | 2017 | 5 | 0.180 |
Why?
|
Foot | 1 | 2019 | 10 | 0.180 |
Why?
|
Blood Volume | 1 | 2019 | 5 | 0.180 |
Why?
|
Choice Behavior | 1 | 2020 | 75 | 0.180 |
Why?
|
Infant | 1 | 2022 | 1014 | 0.170 |
Why?
|
Risk Factors | 4 | 2015 | 3414 | 0.170 |
Why?
|
Methylergonovine | 1 | 2018 | 3 | 0.160 |
Why?
|
Vasopressins | 1 | 2018 | 12 | 0.160 |
Why?
|
Colposcopy | 1 | 2018 | 13 | 0.160 |
Why?
|
Privacy | 1 | 2017 | 7 | 0.160 |
Why?
|
Obesity, Morbid | 1 | 2017 | 17 | 0.160 |
Why?
|
Sodium Bicarbonate | 1 | 2017 | 8 | 0.160 |
Why?
|
Vacuum Extraction, Obstetrical | 1 | 2017 | 5 | 0.150 |
Why?
|
Feasibility Studies | 1 | 2018 | 196 | 0.150 |
Why?
|
Parity | 1 | 2017 | 46 | 0.150 |
Why?
|
Clinical Competence | 2 | 2019 | 124 | 0.150 |
Why?
|
Blood Transfusion | 1 | 2017 | 26 | 0.150 |
Why?
|
Heparin | 1 | 2017 | 34 | 0.150 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 118 | 0.150 |
Why?
|
Longitudinal Studies | 1 | 2019 | 841 | 0.150 |
Why?
|
Reference Values | 2 | 2019 | 204 | 0.140 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 44 | 0.140 |
Why?
|
Tranexamic Acid | 1 | 2015 | 1 | 0.140 |
Why?
|
Antifibrinolytic Agents | 1 | 2015 | 3 | 0.140 |
Why?
|
Hormone Antagonists | 1 | 2015 | 15 | 0.140 |
Why?
|
Patient-Centered Care | 1 | 2016 | 51 | 0.140 |
Why?
|
Infant, Low Birth Weight | 1 | 2015 | 37 | 0.140 |
Why?
|
Complementary Therapies | 1 | 2016 | 45 | 0.140 |
Why?
|
Postpartum Hemorrhage | 1 | 2015 | 7 | 0.130 |
Why?
|
Chi-Square Distribution | 2 | 2015 | 213 | 0.130 |
Why?
|
Peer Group | 1 | 2016 | 138 | 0.130 |
Why?
|
Version, Fetal | 1 | 2015 | 3 | 0.130 |
Why?
|
Amnion | 1 | 2015 | 17 | 0.130 |
Why?
|
Breech Presentation | 1 | 2015 | 4 | 0.130 |
Why?
|
Analgesia, Obstetrical | 1 | 2015 | 4 | 0.130 |
Why?
|
Nerve Block | 1 | 2015 | 6 | 0.130 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2015 | 39 | 0.130 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 217 | 0.130 |
Why?
|
Cohort Studies | 4 | 2023 | 1422 | 0.130 |
Why?
|
Incontinence Pads | 1 | 2014 | 3 | 0.130 |
Why?
|
Disposable Equipment | 1 | 2014 | 5 | 0.130 |
Why?
|
Fecal Incontinence | 1 | 2014 | 3 | 0.130 |
Why?
|
Validation Studies as Topic | 1 | 2014 | 8 | 0.130 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 41 | 0.130 |
Why?
|
Urodynamics | 1 | 2014 | 4 | 0.130 |
Why?
|
Lifting | 1 | 2014 | 5 | 0.130 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 112 | 0.130 |
Why?
|
Patient Simulation | 1 | 2014 | 13 | 0.130 |
Why?
|
Postoperative Care | 1 | 2014 | 18 | 0.130 |
Why?
|
Cough | 1 | 2014 | 17 | 0.130 |
Why?
|
Papillomaviridae | 1 | 2015 | 125 | 0.120 |
Why?
|
Child | 1 | 2022 | 2875 | 0.120 |
Why?
|
Posture | 1 | 2014 | 57 | 0.120 |
Why?
|
Trauma Severity Indices | 1 | 2014 | 26 | 0.120 |
Why?
|
Clinical Clerkship | 1 | 2014 | 23 | 0.120 |
Why?
|
Philippines | 1 | 2014 | 72 | 0.120 |
Why?
|
Movement | 1 | 2014 | 86 | 0.120 |
Why?
|
Hysterectomy | 1 | 2013 | 29 | 0.120 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 142 | 0.120 |
Why?
|
Search Engine | 1 | 2013 | 6 | 0.120 |
Why?
|
China | 1 | 2014 | 178 | 0.120 |
Why?
|
Parents | 1 | 2016 | 288 | 0.120 |
Why?
|
Japan | 1 | 2014 | 296 | 0.120 |
Why?
|
Robotics | 1 | 2013 | 43 | 0.110 |
Why?
|
Heart Rate | 1 | 2014 | 248 | 0.110 |
Why?
|
Public Health | 2 | 2020 | 348 | 0.110 |
Why?
|
Anesthetics, Local | 1 | 2012 | 21 | 0.110 |
Why?
|
Women | 1 | 2012 | 26 | 0.110 |
Why?
|
Extraction, Obstetrical | 1 | 2012 | 3 | 0.110 |
Why?
|
Risk Assessment | 1 | 2015 | 727 | 0.110 |
Why?
|
Episiotomy | 1 | 2012 | 6 | 0.110 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 292 | 0.110 |
Why?
|
Laparoscopy | 2 | 2013 | 54 | 0.110 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2015 | 248 | 0.110 |
Why?
|
Access to Information | 1 | 2012 | 13 | 0.110 |
Why?
|
Vagina | 1 | 2012 | 81 | 0.100 |
Why?
|
Drug Combinations | 1 | 2011 | 89 | 0.100 |
Why?
|
Postoperative Hemorrhage | 1 | 2010 | 14 | 0.100 |
Why?
|
Interviews as Topic | 2 | 2010 | 356 | 0.100 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 424 | 0.100 |
Why?
|
Blood Pressure | 1 | 2014 | 613 | 0.100 |
Why?
|
Body Weight | 1 | 2012 | 404 | 0.100 |
Why?
|
Hemoglobins | 1 | 2010 | 101 | 0.090 |
Why?
|
Maternal Age | 1 | 2010 | 27 | 0.090 |
Why?
|
Chorioamnionitis | 1 | 2010 | 6 | 0.090 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 465 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 145 | 0.090 |
Why?
|
Private Practice | 1 | 2009 | 2 | 0.090 |
Why?
|
Teaching Rounds | 1 | 2009 | 4 | 0.090 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 13 | 0.090 |
Why?
|
Program Development | 1 | 2011 | 225 | 0.090 |
Why?
|
Age Distribution | 1 | 2010 | 223 | 0.090 |
Why?
|
Migraine Disorders | 1 | 2009 | 6 | 0.090 |
Why?
|
Program Evaluation | 1 | 2011 | 316 | 0.090 |
Why?
|
Patient Compliance | 1 | 2011 | 202 | 0.090 |
Why?
|
Aged | 3 | 2018 | 6448 | 0.090 |
Why?
|
Health Status Indicators | 1 | 2009 | 73 | 0.090 |
Why?
|
Patient Participation | 1 | 2010 | 68 | 0.090 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 92 | 0.090 |
Why?
|
Anxiety | 1 | 2016 | 705 | 0.090 |
Why?
|
Quality of Health Care | 1 | 2009 | 136 | 0.080 |
Why?
|
Equipment Failure | 1 | 2008 | 11 | 0.080 |
Why?
|
Device Removal | 1 | 2008 | 9 | 0.080 |
Why?
|
Intestine, Small | 1 | 2008 | 24 | 0.080 |
Why?
|
Hypertension | 1 | 2015 | 770 | 0.080 |
Why?
|
Blood Glucose | 1 | 2010 | 333 | 0.080 |
Why?
|
Educational Status | 1 | 2009 | 295 | 0.080 |
Why?
|
Aged, 80 and over | 1 | 2014 | 2333 | 0.080 |
Why?
|
Psychometrics | 1 | 2009 | 292 | 0.080 |
Why?
|
Minority Groups | 2 | 2023 | 537 | 0.080 |
Why?
|
Case-Control Studies | 1 | 2010 | 1056 | 0.070 |
Why?
|
Stroke | 1 | 2009 | 274 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2011 | 583 | 0.070 |
Why?
|
Vaginal Smears | 1 | 2005 | 52 | 0.070 |
Why?
|
Fetal Tissue Transplantation | 1 | 2022 | 4 | 0.060 |
Why?
|
Aborted Fetus | 1 | 2022 | 5 | 0.050 |
Why?
|
Pain, Postoperative | 1 | 2022 | 22 | 0.050 |
Why?
|
Pelvic Pain | 1 | 2022 | 9 | 0.050 |
Why?
|
Abortion, Legal | 1 | 2021 | 6 | 0.050 |
Why?
|
Drug and Narcotic Control | 1 | 2021 | 10 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 22 | 0.050 |
Why?
|
Aftercare | 1 | 2021 | 18 | 0.050 |
Why?
|
Guam | 1 | 2021 | 76 | 0.050 |
Why?
|
Menstruation | 1 | 2020 | 10 | 0.050 |
Why?
|
Amenorrhea | 1 | 2020 | 1 | 0.050 |
Why?
|
Survival Analysis | 1 | 2020 | 322 | 0.040 |
Why?
|
Self Administration | 1 | 2019 | 41 | 0.040 |
Why?
|
Biomedical Research | 1 | 2023 | 371 | 0.040 |
Why?
|
Medicaid | 1 | 2020 | 102 | 0.040 |
Why?
|
Databases, Factual | 1 | 2019 | 288 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2019 | 528 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2018 | 50 | 0.040 |
Why?
|
Nonprescription Drugs | 1 | 2017 | 6 | 0.040 |
Why?
|
Telephone | 1 | 2017 | 32 | 0.040 |
Why?
|
Decision Making | 1 | 2019 | 189 | 0.040 |
Why?
|
Health Expenditures | 1 | 2017 | 30 | 0.040 |
Why?
|
Sexual Partners | 1 | 2019 | 308 | 0.040 |
Why?
|
Samoa | 1 | 2015 | 17 | 0.030 |
Why?
|
Fetal Macrosomia | 1 | 2015 | 13 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 375 | 0.030 |
Why?
|
Family Relations | 1 | 2015 | 45 | 0.030 |
Why?
|
Anesthesia, Spinal | 1 | 2015 | 2 | 0.030 |
Why?
|
Anesthesia, Epidural | 1 | 2015 | 3 | 0.030 |
Why?
|
Analgesia, Epidural | 1 | 2015 | 6 | 0.030 |
Why?
|
Decision Trees | 1 | 2015 | 18 | 0.030 |
Why?
|
Cost Savings | 1 | 2015 | 14 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2015 | 20 | 0.030 |
Why?
|
Hospital Costs | 1 | 2015 | 22 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 54 | 0.030 |
Why?
|
Family Characteristics | 1 | 2015 | 102 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 555 | 0.030 |
Why?
|
Genital Diseases, Female | 1 | 2013 | 37 | 0.030 |
Why?
|
Canada | 1 | 2013 | 121 | 0.030 |
Why?
|
Social Support | 1 | 2015 | 356 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2015 | 301 | 0.030 |
Why?
|
Information Dissemination | 1 | 2012 | 58 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2010 | 570 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2010 | 1003 | 0.020 |
Why?
|